Glycogen synthase kinase-3 (GSK3) has recently been linked to mood disorders and schizophrenia and the neurotransmitter systems and therapeutic treatments associated with these diseases. Because of changes in these neurotransmitter systems and the actions of therapeutic drugs GSK3 has been linked to the mood disorders bipolar Rabbit polyclonal to AnnexinVI. disorder and depressive disorder and… Continue reading Glycogen synthase kinase-3 (GSK3) has recently been linked to mood disorders